Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2012
02/08/2012EP2415760A2 CCR-9 antagonists
02/08/2012EP2415759A1 CETP inhibitors
02/08/2012EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
02/08/2012EP2414349A1 3-ý1,4¨oxazepane-4-pyrimidone derivatives
02/08/2012EP2414348A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
02/08/2012EP2414347A1 P38map kinase inhibitor
02/08/2012EP2414346A1 Autotaxin inhibitors
02/08/2012EP2414345A1 Method for producing pyridyl-substituted pyrazoles
02/08/2012EP2414344A1 Substituted indolo-pyridinone compounds
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012EP2414328A2 Dihydroorotate dehydrogenase inhibitors
02/08/2012EP2414327A1 Heterocyclic compounds as autotaxin inhibitors
02/08/2012EP2413701A1 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
02/08/2012EP2176251B1 5-pyridinone substituted indazoles and pharmaceutical compositions thereof
02/08/2012EP2148874B1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
02/08/2012EP2148853B1 Insecticidal aryl pyrrolidines
02/08/2012EP2144898B1 Heterocyclic hydrazide compound and pesticidal use of the same
02/08/2012EP2121653B1 Carboxamide compounds and their use as calpain inhibitors
02/08/2012EP1509518B1 Calcium receptor modulating agents
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN102348703A Compounds for the treatment of metabolic disorders
02/08/2012CN102348702A Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
02/08/2012CN102348686A Bis aromatic compounds for use as ltc4 synthase inhibitors
02/08/2012CN102348682A 1,1,1-trifluoro-2-hydroxypropyl compounds
02/08/2012CN102344446A Cis-nitenpyram analog containing carboxylic acid-substituted methyl ester and preparation method and application thereof
02/08/2012CN102344443A Open-loop maleimide compound utilizing click chemosynthesis and application in treating diseases thereof
02/08/2012CN102344440A Anticoccidial compound for livestock and poultry and preparation method thereof
02/08/2012CN102344439A Cis-nitenpyram analogue containing amino acid diol monoester, preparation and application thereof
02/08/2012CN102344438A Crystals of quinoline derivative and preparation methods thereof
02/08/2012CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
02/08/2012CN102342938A Methods and compositions for treatment and management of cancers
02/08/2012CN101575318B 二氢嘧啶类化合物及其用于制备治疗和/或预防病毒性疾病的药物的用途 Dihydro-pyrimidine compounds and their use for preparing medicaments for treating and / or preventing viral drug
02/08/2012CN101573337B 作为抗肿瘤剂的5、6或7-取代-3-(杂)芳基-异喹啉胺衍生物 5, 6 or 7 as an anti-tumor agent is a substituted 3- (hetero) aryl - isoquinoline derivatives of the amine
02/08/2012CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance
02/08/2012CN101410394B 抑制人免疫缺陷病毒的5-(羟基亚甲基和氨基亚甲基)取代的嘧啶 Inhibition of human immunodeficiency virus 5- (hydroxymethylene and aminomethylene) pyrimidine substituted
02/07/2012US8110683 Piperidinyl compounds that selectively bind integrins
02/07/2012US8110681 Compounds for the treatment of spinal muscular atrophy and other uses
02/07/2012US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
02/07/2012US8110579 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
02/07/2012US8110574 Derivatives of 4-aminopiperidine and their use as a medicament
02/07/2012CA2669915C Substituted bicyclocarboxyamide compounds
02/07/2012CA2663366C Compounds and compositions as protein kinase inhibitors
02/07/2012CA2648569C Pyridyl amide t-type calcium channel antagonists
02/07/2012CA2516514C Arylvinylazacycloalkane compounds and methods of preparation and use thereof
02/07/2012CA2507889C Process for preparing (s)-pantoprazole
02/07/2012CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
02/07/2012CA2486836C Multi-substituted imidazolines and method of use thereof
02/07/2012CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/07/2012CA2467119C Novel flame retarding compounds
02/02/2012WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012WO2012016001A1 Cyclic amine azaheterocyclic carboxamides
02/02/2012WO2012015999A2 Process for the preparation of imatinib mesylate
02/02/2012WO2012015986A2 Substituted dioxopiperidinyl phtalimide derivatives
02/02/2012WO2012015723A1 Sulfonamide compounds useful as cyp17 inhibitors
02/02/2012WO2012015324A1 Process for the synthesis of substituted urea compounds
02/02/2012WO2012015024A1 Ethinyl-pyrazole derivative
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
02/02/2012WO2012014963A1 Condensed ring pyridine compound
02/02/2012WO2012014910A1 P2x4 receptor antagonist
02/02/2012WO2012014699A1 Therapeutic agent for neurological diseases
02/02/2012WO2012014000A1 STABLE α-CRYSTAL FORM OF IMATINIB MESYLATE AND PREPARING PROCESS THEREOF
02/02/2012WO2012013754A1 Novel microbiocidal dioxime ether derivatives
02/02/2012WO2012013728A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
02/02/2012WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors
02/02/2012WO2012013643A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012WO2012012891A1 Compounds, compositions and methods for treatment of arthritis
02/02/2012WO2012012890A1 Compounds, compositions and methods for treatment of arthritis
02/02/2012WO2011156901A3 Compounds, compositions and methods for treatment of multiple sclerosis
02/02/2012WO2011127388A3 Inverse agonists and neutral antagonists for the tsh receptor
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012US20120029192 Pyrazole Derivatives
02/02/2012US20120029189 Process for the preparation of histamine h3 receptor modulators
02/02/2012US20120029188 Substituted Aniline Derivatives
02/02/2012US20120029027 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029023 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
02/02/2012US20120029021 Nitroxide Free Radical Synergized Antineoplastic Agents
02/02/2012US20120029020 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029019 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029012 5, 6, or 7-SUBSTITUTED -3-(HETERO) ARYLISOQUINOLINAMINE DERIVATIVES AND THERAPEUTIC USE THEREOF
02/02/2012US20120029011 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
02/02/2012US20120029002 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
02/02/2012US20120029000 Process for the preparation of alogliptin
02/02/2012US20120028997 Prokineticin 1 receptor antagonists
02/02/2012US20120028994 Compounds for the reduction of beta-amyloid production
02/02/2012US20120028988 Use of pyridazinone compound for control of harmful arthropod pests
02/02/2012US20120028987 Bicyclic Benzamides of 3-Or-4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
02/02/2012US20120028983 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/02/2012US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors
02/02/2012US20120028978 Substituted bicyclic hcv inhibitors
02/02/2012US20120028970 Heteroarylthiomethyl pyridine derivative
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028961 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028956 Bicyclic mglur5 positive allosteric modulators and methods of making and using same